Estimating rates of immune-related adverse events in an Australian state-wide hospital population

Collaboration Agreement for Value Based Healthcare Project 5.2 Immuno-oncology related adverse events: feasiblity of risk prediction in clinical practice.

PRedicting the population health economic IMpact of current and new CAncer Treatments (PRIMCAT)

Dr Fanny Franchini and Professor Maarten IJzerman, together with colleagues in the University of Melbourne, the University of New South Wale..